BSE Live
Feb 03, 16:01Prev. Close
63.17
Open Price
65.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Feb 03, 15:53Prev. Close
64.01
Open Price
64.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
64.95 (5153)
| Key Financial Ratios of Aarey Drugs and Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 1.42 | 1.67 | 1.49 | 2.72 | 2.79 | |
| Diluted EPS (Rs.) | 1.42 | 1.67 | 1.49 | 2.72 | 2.79 | |
| Cash EPS (Rs.) | 2.10 | 2.27 | 2.11 | 3.36 | 3.18 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 48.67 | 47.33 | 46.25 | 44.77 | 42.28 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 48.67 | 47.33 | 46.25 | 44.77 | 42.28 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 166.56 | 141.02 | 165.04 | 194.09 | 148.99 | |
| PBDIT/Share (Rs.) | 4.47 | 4.07 | 4.12 | 5.52 | 4.98 | |
| PBIT/Share (Rs.) | 3.78 | 3.46 | 3.50 | 4.74 | 4.59 | |
| PBT/Share (Rs.) | 2.14 | 1.90 | 2.37 | 3.95 | 3.55 | |
| Net Profit/Share (Rs.) | 1.41 | 1.67 | 1.49 | 2.58 | 2.79 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 2.68 | 2.88 | 2.49 | 2.84 | 3.34 | |
| PBIT Margin (%) | 2.27 | 2.45 | 2.11 | 2.44 | 3.08 | |
| PBT Margin (%) | 1.28 | 1.35 | 1.43 | 2.03 | 2.38 | |
| Net Profit Margin (%) | 0.84 | 1.18 | 0.90 | 1.32 | 1.86 | |
| Return on Networth / Equity (%) | 2.90 | 3.52 | 3.21 | 5.75 | 6.58 | |
| Return on Capital Employed (%) | 7.61 | 7.10 | 7.20 | 10.44 | 10.68 | |
| Return on Assets (%) | 1.38 | 1.54 | 1.29 | 2.66 | 2.79 | |
| Total Debt/Equity (X) | 0.25 | 0.24 | 0.32 | 0.12 | 0.18 | |
| Asset Turnover Ratio (%) | 1.60 | 1.33 | 1.56 | 2.06 | 149.51 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.78 | 1.70 | 1.61 | 1.74 | 1.65 | |
| Quick Ratio (X) | 1.48 | 1.49 | 1.44 | 1.63 | 1.51 | |
| Inventory Turnover Ratio (X) | 11.83 | 0.00 | 0.00 | 0.00 | 18.87 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 129.30 | 155.10 | 97.10 | 119.06 | 71.62 | |
| EV/Net Operating Revenue (X) | 0.27 | 0.39 | 0.23 | 0.24 | 0.21 | |
| EV/EBITDA (X) | 10.17 | 13.59 | 9.29 | 8.50 | 6.15 | |
| MarketCap/Net Operating Revenue (X) | 0.20 | 0.32 | 0.14 | 0.21 | 0.16 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 0.69 | 0.94 | 0.51 | 0.92 | 0.55 | |
| Price/Net Operating Revenue | 0.20 | 0.32 | 0.14 | 0.21 | 0.16 | |
| Earnings Yield | 0.04 | 0.04 | 0.06 | 0.06 | 0.12 |
14.11.2025
Aarey Drugs Standalone September 2025 Net Sales at Rs 84.16 crore, down 19.96% Y-o-Y
21.11.2024
Aarey Drugs Standalone September 2024 Net Sales at Rs 105.14 crore, up 81.81% Y-o-Y
19.08.2024
Aarey Drugs Standalone June 2024 Net Sales at Rs 126.91 crore, up 149.06% Y-o-Y
07.06.2024
Aarey Drugs Standalone March 2024 Net Sales at Rs 210.35 crore, up 32.98% Y-o-Y